CHKB anticorps (C-Term)
Aperçu rapide pour CHKB anticorps (C-Term) (ABIN5530820)
Antigène
Voir toutes CHKB AnticorpsReactivité
Hôte
Clonalité
Conjugué
Application
-
-
Épitope
- AA 356-386, C-Term
-
Purification
- This antibody is prepared by Saturated Ammonium Sulfate (SAS) precipitation followed by dialysis
-
Immunogène
- This Ethanolamine Kinase (EKI1) antibody is generated from rabbits immunized with a KLH conjugated synthetic peptide between 356-386 amino acids from the C-terminal region of human Ethanolamine Kinase (EKI1).
-
Isotype
- Ig Fraction
-
-
-
-
Indications d'application
- For WB starting dilution is: 1:1000
-
Restrictions
- For Research Use only
-
-
-
Format
- Liquid
-
Concentration
- 2 mg/mL
-
Buffer
- Supplied in PBS with 0.09 % (W/V) sodium azide.
-
Agent conservateur
- Sodium azide
-
Précaution d'utilisation
- This product contains Sodium azide: a POISONOUS AND HAZARDOUS SUBSTANCE which should be handled by trained staff only.
-
Stock
- 4 °C,-20 °C
-
Stockage commentaire
- Store at 4°C for three months and -20°C, stable for up to one year. As with all antibodies care should be taken to avoid repeated freeze thaw cycles. Antibodies should not be exposed to prolonged high temperatures.
-
-
- CHKB (Choline Kinase beta (CHKB))
-
Autre désignation
- Ethanolamine Kinase
-
Sujet
- Ethanolamine kinase 1 (EKI1), functions in the first committed step of the phosphatidylethanolamine synthesis pathway. This cytosolic enzyme is specific for ethanolamine and exhibits negligible kinase activity on choline.
-
Poids moléculaire
- 51 kDa
-
ID gène
- 55500
-
UniProt
- Q9HBU6
Antigène
-